Julia K Cole

Bringing Awareness to Breast Cancer and Breast Cancer Research through my sig tags. Here are a few of my BCA and BCR 2014 sig tags featuring the fabulous artwork of  Elias, Garv and RAC

If you are a fan of all things paranormal then check out Brent Raynes' interview with Brad Steiger over at AP Magazine (Alternate Perceptions Magazine)  Here's the link: http://apmagazine.info/index.php/component/content/article?id=476 Merry Christmas!

Last week when the government re-opened, thousands of furloughed employees who were struggling to get by without a paycheck rejoiced. I celebrated for another reason -- because thousands of people like me with cancer will be able to resume treatment and clinical trials through the National Institutes of Health.  I started a petition on Change.org when the government shut down shortly after I applied to enter a clinical trial for my cancer that was federally funded. Over 150,683 people signed -- including you -- giving a voice to people like me who were directly impacted by the shutdown.  Thanks to you and everyone who signed, my story was highlighted by news outlets like Reuters, The Washington Post , MSNBC and the BBC. By lifting up the voices of those who were hit hardest by the government shutdown, you and I contributed to the national outrage that pressured our nation's leaders to reach a deal and reopen as quickly as possible. When this began, I...

Sign up to participate in a breast cancer walk today and let's finish the fight against breast cancer that the American Cancer Society started 100 years ago.     Click HERE *~*~* When you participate in a Making Strides Against Breast Cancer walk, you are sharing your passion and raising funds to help save lives from breast cancer.  Sign up for a Making Strides walk near you, and make a difference with every step you take. Find an event today!  Click HERE TOGETHER we can make Strides Against Breast Cancer!

Stem cell research continues to excite the field of MS research as a new Phase I trial involving the use of stems cells as an Investigational New Drug (IND) in MS patients has been approved by the Food and Drug Administration (FDA).  The small Phase I clinical trial will investigate the safety and efficacy of autologous, mesenchymal stems cell-derived neural progenitor cells (MSC-NPs) in the treatment of progressive MS. Neural progenitor cells are cells that can develop into neurons and other nervous system cells, such as oligodendrocytes, encouraging neural repair and regeneration as evidenced in studies with mice (Harris, 2012).  Mesenchymal stem cells (MSCs) are adult stem cells derived from bone marrow which can differentiate into other types of cells such as neural progenitor cells (NPCs).  Autologous mesenchymal stem cells are obtained from a person’s (or animal’s) own bone marrow. Led by Saud Sadiq, MD and Violaine Harris, PhD, researchers at the Tisch MS...